Cipher Uses DSG`s EDC in Effort to Give Hope to Severe Acne Sufferers

-Cipher Pharmaceuticals conducts Phase 3 trial study for new severe acne
treatment-
MALVERN, Pa.--(Business Wire)--
DSG Inc., an industry leader in clinical trial data collection and management,
today announced that Cipher Pharmaceuticals (TSX:DND) is using electronic data
capture (EDC) software and data management services from DSG. Cipher is using
DSG`s eCaseLink for its Phase 3 dermatology study on its new compound for the
treatment of severe acne. Cipher`s new treatment offers new hope for patients
with severe inflammatory or recalcitrant nodular acne who are unresponsive to
conventional therapy.

DSG`s eCaseLink makes it possible to merge and analyze a highly complex array of
widely varied data across a large patient base. Cipher is using DSG`s integrated
data management services for all aspects of database design, usage, freeze, lock
and archiving at 50 sites throughout the U.S. and Canada with 800 patients
estimated to complete the study over an anticipated 18 month period.

"As we move forward with our clinical trial process it is essential that we have
the latest in EDC and data management technology that reduces overall trial
costs and improves data quality," said Jason A. Gross, Pharm.D., Vice President
of Scientific Affairs, Cipher Pharmaceuticals. "DSG`s EDC offering in
combination with integrated data management helps us meet our objectives to
bring the latest therapies to market."

"DSG is proud to be supporting Cipher Pharmaceuticals through its critical Phase
3 study," said Tony Varano, CEO, DSG, Inc. "We are confident that our integrated
approach to EDC and data management will reap tangible benefits in controlling
costs and ensuring study success at Cipher, putting a new face on a proven
treatment for severe acne."

About DSG

DSG Inc., ranked no. 82 on the Inc. 500, supports clinical trial data collection
and management with innovative technology solutions including Electronic Data
Capture with specialized Clinical Data Management services, IWRS (web-based
patient randomization and drug/device supply management), Clinical Trial
Management Systems and digital on-demand Case Report Form publishing management
software. DSG`s products allow user-friendly, accurate and efficient data
capture at any investigator site regardless of the technological infrastructure.
DSG has successfully supported over 1000 clinical trials for more than 325
companies at over 18,000 sites in over 68 countries. Founded in 1992, DSG is a
global company headquartered in Malvern, Pa., with additional offices in the
U.S., Japan and India. For more information, please visit www.dsg-us.com.

All products and services mentioned in this announcement are the property of
their respective owners.

DSG Inc.
David Grace, +1 484-913-0210 x109
dgrace@dsg-us.com

Copyright Business Wire 2009